Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1998-9-18
|
| pubmed:abstractText |
Current clinical and pathologic methods are imprecise in predicting the extent of prostate carcinoma progression. This study was conducted to evaluate the role of interphase cytogenetics (ICG) with chromosome enumeration probes relative to the role of conventional pathologic characteristics in the preoperative prediction of postoperative tumor classification and recurrence of elevated serum concentrations of prostate specific antigen (PSA).
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0008-543X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
83
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
977-88
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9731903-Adenocarcinoma,
pubmed-meshheading:9731903-Biopsy, Needle,
pubmed-meshheading:9731903-Chromosome Aberrations,
pubmed-meshheading:9731903-Humans,
pubmed-meshheading:9731903-Interphase,
pubmed-meshheading:9731903-Male,
pubmed-meshheading:9731903-Prognosis,
pubmed-meshheading:9731903-Prostate-Specific Antigen,
pubmed-meshheading:9731903-Prostatectomy,
pubmed-meshheading:9731903-Prostatic Neoplasms
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma.
|
| pubmed:affiliation |
Institute of Pathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|